SynthesisFrontiers in immunology2024

Efficacy and safety of PD-1/L1 inhibitors as first-line therapy for metastatic colorectal cancer: a meta-analysis.

Zhilong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.